ArticleBioengineering (Basel, Switzerland)2025
A Lightweight Machine Learning Model for High Precision Gastrointestinal Stromal Tumors Identification.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gastrointestinal stromal tumors (GISTs), which usually develop with a significant malignant potential, are a serious challenge in stromal health. With Endoscopic ultrasound (EUS), GISTs can appear similar to other tumors. This study introduces a lightweight convolutional neural network model optimized for the classification of GISTs and leiomyomas using EUS images only. Models are constructed based on a dataset that comprises 13277 augmented grayscale images derived from 703 patients, ensuring a balanced representation between GIST and leiomyoma cases. The optimized model architecture includes seven convolutional units followed by fully connected layers. After being trained and evaluated with a 5-fold cross-validation, the optimized model achieves an average validation accuracy of 96.2%. The model achieved a sensitivity, specificity, positive predictive value, and negative predictive value of 97.7%, 94.7%, 94.6%, and 97.7%, respectively, and significantly outperformed endoscopists' assessments. The study highlights the model's robustness and consistency. Our results suggest that instead of using developed deep models with fine-tuning, lightweight models with their simpler designs may grasp the essence and drop speckle noise. A lightweight model as a hypothesis with fewer model parameters is preferable to a deeper model with 10 times the model parameters according to Occam's razor statement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.